Glucan-resveratrol-vitamin C combination offers protection against toxic agents

Toxins

Volumn 4, Issue 11, 2012, Pages 1301-1308

  Vetvicka, Vaclav ^a   Vetvickova, Jana ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Glucan; Mercury; PFOA; PFOS; Resveratrol; Vitamin C

Indexed keywords

ASCORBIC ACID; BETA 1,3 GLUCAN; GAMMA INTERFERON; GLUCAN; HYDROCARBON; IMMUNOMODULATING AGENT; IMMUNOTOXIN; INTERLEUKIN 12; INTERLEUKIN 6; MERCURY; METHYLMERCURY; PERFLUORO COMPOUND; RESVERATROL; THIOMERSAL; TOXIC SUBSTANCE;

ANTIBODY RESPONSE; CELL PROLIFERATION; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL ACTIVITY; IMMUNOSTIMULATION; IMMUNOTHERAPY; MERCURIALISM; REVIEW; WOUND INFECTION;

ANIMALS; ASCORBIC ACID; DRUG COMBINATIONS; ENVIRONMENTAL POLLUTANTS; GLUCANS; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; NEOPLASMS; PROTECTIVE AGENTS; STILBENES; THIMEROSAL;

ANIMALIA;

EID: 84870529675     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins4111301     Document Type: Review

References (36)

1. Tryphonas, H. Approaches to detecting immunotoxic effects of environmental contaminants in humans. Environ. Health Perspect. 2001, 109, 877-884.
2. Magos, L. Review of the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products. J. Appl. Toxicol. 2001, 21, 1-5.
3. Yole, M.; Wickstrom, M.; Blakley, B. Cell death and cytotoxic effects in YAC-1 lymphome cells following exposure to variosu forms of mercury. Toxicol. J. 2007, 231, 40-57.
4. Santarelli, L.; Bracii, M.; Mocchyeegiani, E. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, INF-g, IL-6): Role of the nitric oxide-L-arginine pathway. Int. Immunopathol. 2006, 6, 376-389.
5. Descotes, J. Immunotoxicity of Drugs and Chemicals: An Experimental and Clinical Approach; Elsevier: Amsterdam, The netherlands, 2004.
6. Fillipov, N.M.; Pinchuk, L.M.; Boyd, B.L.; Crittenden, P.L. Immunotoxic effects of short-term atrazine exposure in young male C57BL/6 mice. Toxicol. Sci. 2005, 86, 324-332.
7. Khan, N.M.; Poduval, T.B. Immunomodulatory and immunotoxic effects of bilirubin: Molecular mechanisms. J. Leukoc. Biol. 2011, 90, 997-1015.
8. Vetvicka, V.; Fornusek, L.; Sima, P.; Bilej, M.; Táborsky, L.; Rihova, B.; Simeckova, J.; Miler, I. Effects of bilirubin on murine peritoneal and spleen cells. Acta Pathol. Microbiol. Immunol. Scand. 1988, 96, 671-675.
9. Dass, K.K.; Das, S.N.; Dhundasi, S.A. Nickel, its adverse health effects & oxidative stress. Indian J. Med. Res. 2008, 128, 412-425.
10. Benacerraf, B.; Sebestyen, M.M. Effect of bacterial endotoxins on the reticuloendothelial system. Fed. Proc. 1957, 16, 860-867.
11. Vetvicka, V.; Novak, M. Biological Action of β-glucan. In Biology and Chemistry of Beta Glucan; Vetvicka, V., Novak, M., Eds.; Bentham Science Publishers: Oak Park, IL, USA, 2011; pp. 10-18.
12. Novak, M.; Vetvicka, V. Glucans as biological response modifiers. Endocr. Metab. Immune Disord. Drug Targets 2009, 9, 67-75.
13. Ditteova, G.; Velebny, S.; Hrckova, G. Modulation of liver fibrosis and pathophysiological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C. J. Helminthol. 2003, 77, 219-226.
14. Verlhac, V.; Gabaudan, J.; Obach, A.; Schuep, W.; Hole, R. Influence of dietary glucan and vitamin C on non-specifc and specific immune responses of rainbow trout (Onchorhynchus mykiss). Aquaculture 1996, 143, 123-133.
15. Vetvicka, V.; Baigorri, R.; Zamarreno, A.M.; Garcia-Minam J.M.; Yvin, J.C. Glucan and humic acids: Synergistic effects on the immune system. J. Med. Food 2010, 13, 863-869.
16. Vetvicka, V.; Volny, T.; Saraswat-Ohri, S.; Vashishta, A.; Vancikova, Z.; Vetvickova, J. Glucan and resveratrol complex-Possible synergistic effects on immune system. Biomed. Pap. Med. Fac. Univ. Palacky 2007, 151, 41-46.
17. Vetvicka, V.; Vetvickova, J. Combination of glucan, resveratrol and vitamin C demonstrates strong anti-tumor potential. Anticancer Res. 2012, 32, 81-88.
18. Vetvicka, V.; Vetvickova, J. Effects of glucan on immunosuppressive action of mercury. J. Med. Food 2009, 12, 1098-1104.
19. Vetvicka, V. β-Glucans as immunomodulators. JANA 2001, 3, 31-34.
20. Vetvicka, V.; Dvorak, B.; Vetvickova, J.; Richter, J.; Krizan, J.; Sima, P.; Yvin, J.C. Orally administered marine (1→3)-β-D-glucan Phycarine stimulates both humoral and cellular immunity. Int. J. Biol. Macromol. 2007, 40, 291-298.
21. Novak, M.; Vetvicka, V. Development of Views on β-Glucan Composition and Structure. In Biology and Chemistry of Beta Glucan; Vetvicka, V., Novak, M., Eds.; Bentham Science Publishers: Oak Park, IL, USA, 2011; pp. 1-9.
22. Vetvicka, V.; Vashishta, A.; Saraswat-Ohri, S.; Vetvickova, J. Immunological effects of yeast-and mushroom-derived beta-glucans. J. Med. Food 2008, 11, 615-622.
23. Sarafian, T.A. Methylmercury-induced generatrion of free radicals: biological implications. Met. Ions Biol. Syst. 1996, 36, 415-444.
24. Vetvicka, V.; Vetvickova, J. β-1,3-Glucan: Silver bullet or hot air? Open Glycosci. 2010, 3, 1-6.
25. Quig, D. Cysteine metabolism and metal toxicity. Altern. Med. Rev. 1998, 3, 262-270.
26. Lau, C.; Anitole, K.; Hodes, C.; Lai, D.; Pfahles-Hutchens, A.; Seed, J. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99, 66-94.
27. Dong, G.H.; Zhang, Y.H.; Zheng, L.; Liu, W.; Jin, Y.H.; He, Q.C. Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch. Toxicol. 2009, 83, 805-815.
28. Qazi, M.R.; Bogdanska, J.; Butenhoff, J.L.; Nelson, B.D.; DePierre, J.W.; Bedi-Valugerdi, M. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicol. J. 2009, 262, 207-214.
29. Corsini, E.; Sangiovanni, E.; Avogadro, A.; Galbiati, V.; Viviani, B.; Marinovich, M.; Galli, C.L.; Dell'Agli, M.; Germolec, D.R. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol. Appl. Pharmacol. 2012, 258, 248-255.
30. DeWitt, J.C.; Peden-Adams, M.M.; Keller, J.M.; Germolec, D.R. Immunotoxicity of perfluorinated compounds: Recent developments. Toxicol. Pathol. 2012, 40, 300-311.
31. Grandjean, P.; Andersen, E.W.; Budtz-Jorgensen, E.; Nielsen, F.; Molbak, K.; Weihe, P.; Heilmann, C. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. J. Am. Med. Assoc. 2012, 307, 391-397.
32. Calafat, A.N.; Wong, L.Y.; Kuklenyik, Z.; Reidy, J.A.; Needham, L.L. Polyfluoroalkyl chemicals in the U.S. population: Data from the national health and nutrition examination survey (NHANES) 2003-2004 and comparison with NHANES 1999-2000. Environ. Health Perspect. 2007, 115, 1596-1602.
33. Vetvicka, V.; Vetvickova, J. An evaluation of the immunological activities of commercially available β1,3-glucans. JANA 2007, 10, 25-31.
34. Eicher, S.D.; McKee, C.A.; Carroll, J.A.; Pajor, E.A. Supplemental vitamin C and yeast cell wall beta-glucan as growth enhancers in newborn pigs and as immunomodulators after an endotoxin challenge after weaning. J. Anim. Sci. 2006, 84, 2352-2360.
35. Vetvicka, V.; Vetvickova, J. Comparison of immunological properties of various bioactive combinations. Biomed. Pap. Med. Fac. Univ. Palacky 2012, in press.
36. Bowers, G.J.; Patchen, M.L.; MacVittie, T.J.; Hirsch, E.F.; Fink, M.P. A comparative evaluation of particulate and soluble glucan in an endotoxin model. Int. J. Immunopharmacol. 1986, 8, 313-321.